RxNorm Semantic Concepts Index - 476
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "476".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 476098 | E. coli exonuclease I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 47610 | calcium alginate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 476103 | TNF alpha | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476103 | TNF alpha | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476103 | TNF alpha | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476103 | TNF alpha | Designated preferred name (PT) | NO | |
| RxCUI: 476103 | TNF alpha | Full form of descriptor (FN) | NO | |
| RxCUI: 476103 | TNF alpha | Designated preferred name (PT) | NO | |
| RxCUI: 476103 | TNF alpha | Full form of descriptor (FN) | NO | |
| RxCUI: 476103 | TNF alpha | British preferred term (PTGB) | NO | |
| RxCUI: 476103 | TNF alpha | British preferred term (PTGB) | NO | |
| RxCUI: 47613 | calcium citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 476135 | benzethonium chloride 1.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476137 | benzethonium chloride 0.13 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476137 | benzethonium chloride 0.13 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476137 | benzethonium chloride 0.13 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476143 | abacavir / lamiVUDine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476143 | abacavir / lamiVUDine Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 476152 | butalbital 50 MG / acetaminophen 750 MG / caffeine 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476152 | butalbital 50 MG / acetaminophen 750 MG / caffeine 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476152 | butalbital 50 MG / acetaminophen 750 MG / caffeine 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 47617 | calcium galactogluconate bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 476177 | cloZAPine 100 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476177 | cloZAPine 100 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476177 | cloZAPine 100 MG Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 476178 | cloZAPine Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476178 | cloZAPine Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 476179 | cloZAPine 25 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476179 | cloZAPine 25 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476179 | cloZAPine 25 MG Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 47618 | calcium glucoheptonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 47618 | calcium glucoheptonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476193 | cephalexin 250 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476194 | cephalexin Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 4762 | Genetic code | Designated preferred name (PT) | NO | |
| RxCUI: 4762 | Genetic code | Full form of descriptor (FN) | NO | |
| RxCUI: 47622 | calcium 2-hydroxypropanoate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 47622 | calcium 2-hydroxypropanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 47622 | calcium 2-hydroxypropanoate | Designated preferred name (PT) | YES | |
| RxCUI: 47622 | calcium 2-hydroxypropanoate | Full form of descriptor (FN) | YES | |
| RxCUI: 47622 | calcium 2-hydroxypropanoate | Designated preferred name (PT) | YES | |
| RxCUI: 47622 | calcium 2-hydroxypropanoate | Full form of descriptor (FN) | YES | |
| RxCUI: 47624 | calcium laevulate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 47624 | calcium laevulate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 476250 | duloxetine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 476250 | duloxetine hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 476250 | duloxetine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 476250 | duloxetine hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 476260 | duloxetine hydrochloride 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476260 | duloxetine hydrochloride 60 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 476271 | aminocaproic acid 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476271 | aminocaproic acid 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476272 | 6-aminocaproic acid 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 47628 | tricalcium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 476282 | calcium phosphate 77 MG / cholecalciferol 400 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476282 | calcium phosphate 77 MG / cholecalciferol 400 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476282 | calcium phosphate 77 MG / cholecalciferol 400 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476283 | calcium phosphate 77 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476287 | acetaminophen 635 MG / phenyltoloxamine citrate 55 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476287 | acetaminophen 635 MG / phenyltoloxamine citrate 55 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476287 | acetaminophen 635 MG / phenyltoloxamine citrate 55 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476288 | acetaminophen 635 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476289 | phenyltoloxamine citrate 55 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476294 | acetaminophen 425 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476296 | caffeine 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476297 | acetaminophen / caffeine / phenyltoloxamine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 476299 | amoxicillin trihydrate 600 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 47630 | Calcium polystyrene sulfonate | Designated preferred name (PT) | NO | |
| RxCUI: 47630 | Calcium polystyrene sulfonate | Full form of descriptor (FN) | NO | |
| RxCUI: 47630 | Calcium polystyrene sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 476300 | amoxicillin trihydrate 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476316 | levacecarnine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 476316 | levacecarnine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476317 | acetylcarnitine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 476322 | cefaclor 125 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476322 | cefaclor 125 MG Chewable Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 476322 | cefaclor 125 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476322 | cefaclor 125 MG Chewable Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 476323 | cefaclor 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476324 | cefaclor Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 476325 | cefaclor 187 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476325 | cefaclor 187 MG Chewable Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 476325 | cefaclor 187 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476325 | cefaclor 187 MG Chewable Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 476326 | cefaclor 187 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476327 | cefaclor 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476327 | cefaclor 250 MG Chewable Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 476327 | cefaclor 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476327 | cefaclor 250 MG Chewable Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 47633 | calcium stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 476332 | cetirizine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476345 | ezetimibe 10 MG / simvastatin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476345 | ezetimibe 10 MG / simvastatin 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476345 | ezetimibe 10 MG / simvastatin 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 476345 | ezetimibe 10 MG / simvastatin 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 476348 | ezetimibe / simvastatin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476349 | ezetimibe 10 MG / simvastatin 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476349 | ezetimibe 10 MG / simvastatin 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476349 | ezetimibe 10 MG / simvastatin 20 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 476349 | ezetimibe 10 MG / simvastatin 20 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 476350 | ezetimibe 10 MG / simvastatin 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476350 | ezetimibe 10 MG / simvastatin 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476350 | ezetimibe 10 MG / simvastatin 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 476350 | ezetimibe 10 MG / simvastatin 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 476351 | ezetimibe 10 MG / simvastatin 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476351 | ezetimibe 10 MG / simvastatin 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476351 | ezetimibe 10 MG / simvastatin 80 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 476351 | ezetimibe 10 MG / simvastatin 80 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 476362 | mesalamine 500 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476362 | mesalamine 500 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476365 | methylphenidate Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476368 | methylphenidate Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476398 | carbidopa / levodopa Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476399 | carbidopa 25 MG / levodopa 100 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476399 | carbidopa 25 MG / levodopa 100 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476399 | carbidopa 25 MG / levodopa 100 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476399 | carbidopa 25 MG / levodopa 100 MG Disintegrating Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 476399 | carbidopa 25 MG / levodopa 100 MG Disintegrating Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 476466 | dextromethorphan HBr 15 MG / guaiFENesin 25 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476466 | dextromethorphan HBr 15 MG / guaiFENesin 25 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476466 | dextromethorphan HBr 15 MG / guaiFENesin 25 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 476466 | dextromethorphan HBr 15 MG / guaiFENesin 25 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476466 | dextromethorphan HBr 15 MG / guaiFENesin 25 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 476515 | carbidopa 25 MG / levodopa 250 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476515 | carbidopa 25 MG / levodopa 250 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476515 | carbidopa 25 MG / levodopa 250 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476515 | carbidopa 25 MG / levodopa 250 MG Disintegrating Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 476515 | carbidopa 25 MG / levodopa 250 MG Disintegrating Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 476516 | carbinoxamine maleate 1.5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476516 | carbinoxamine maleate 1.5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476517 | carbinoxamine maleate 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476532 | carbinoxamine tannate 0.72 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476533 | carbinoxamine tannate 0.72 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476535 | carbinoxamine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 476540 | synthetic conjugated estrogens, A 0.45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476540 | synthetic conjugated estrogens, A 0.45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476541 | synthetic conjugated estrogens, A 0.45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476544 | brompheniramine / carbetapentane / phenylephrine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 476545 | estradiol 14 MCG/Day Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476545 | estradiol 14 MCG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476545 | estradiol 14 MCG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476545 | estradiol 14 MCG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476545 | estradiol 14 MCG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476545 | estradiol 14 MCG/Day Weekly Transdermal System | Designated preferred name (PT) | YES | |
| RxCUI: 476545 | estradiol 14 MCG/Day Weekly Transdermal System | Full form of descriptor (FN) | YES | |
| RxCUI: 476546 | estradiol 0.000583 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476549 | calcium carbonate 675 MG (Ca 270 MG) / magnesium hydroxide 135 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476549 | calcium carbonate 675 MG (Ca 270 MG) / magnesium hydroxide 135 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476549 | calcium carbonate 675 MG (Ca 270 MG) / magnesium hydroxide 135 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 47655 | Camostat mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 47655 | Camostat mesilate | Full form of descriptor (FN) | NO | |
| RxCUI: 47655 | Camostat mesilate | Designated preferred name (PT) | NO | |
| RxCUI: 476550 | calcium carbonate 675 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476552 | magnesium hydroxide 135 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476553 | calcium carbonate 675 MG / magnesium hydroxide 135 MG / simethicone 60 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476553 | calcium carbonate 675 MG / magnesium hydroxide 135 MG / simethicone 60 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476553 | calcium carbonate 675 MG / magnesium hydroxide 135 MG / simethicone 60 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476556 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476556 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476556 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476568 | brompheniramine tannate 1.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476576 | cefdinir 250 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476576 | cefdinir 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476576 | cefdinir 250 MG in 5 mL Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 476576 | cefdinir 250 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476576 | cefdinir 250 MG in 5 mL Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 476577 | cefdinir 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476588 | Solifenacin succinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 476588 | Solifenacin succinate | Designated preferred name (PT) | YES | |
| RxCUI: 476588 | Solifenacin succinate | Full form of descriptor (FN) | YES | |
| RxCUI: 476614 | benzoyl peroxide 65 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476616 | benzoyl peroxide 0.065 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476623 | cefaclor 375 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476623 | cefaclor 375 MG Chewable Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 476623 | cefaclor 375 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476623 | cefaclor 375 MG Chewable Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 476628 | vitamin B 12 500 MCG / folic acid 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476628 | vitamin B 12 500 MCG / folic acid 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476628 | vitamin B 12 500 MCG / folic acid 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476628 | vitamin B 12 500 MCG / folic acid 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476668 | green tea extract 375 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476668 | green tea extract 375 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476669 | epigallocatechin gallate 375 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476671 | epigallocatechin gallate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 476673 | gabapentin 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476673 | gabapentin 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476677 | gabapentin 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476677 | gabapentin 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476679 | gabapentin 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476679 | gabapentin 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476704 | guaiFENesin 18 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476704 | guaiFENesin 18 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 476707 | hydroxypropylcellulose 5 MG Ophthalmic Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476707 | hydroxypropylcellulose 5 MG Ophthalmic Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476707 | hydroxypropylcellulose 5 MG Ophthalmic Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476710 | hydroxypropylcellulose Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476731 | guar gum 3000 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476732 | guar gum 3000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476734 | guar gum Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 476740 | iron succinyl milk protein complex Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476742 | iron carbonyl 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 476784 | hydrocortisone 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476785 | aloe polysaccharide 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476786 | aloe polysaccharide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 476787 | iodoquinol 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476809 | mirtazapine 7.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476809 | mirtazapine 7.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 476809 | mirtazapine 7.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476809 | mirtazapine 7.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 476810 | mirtazapine 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476817 | Glucosamine sulfate sodium chloride | Designated preferred name (PT) | NO | |
| RxCUI: 476817 | Glucosamine sulfate sodium chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 476818 | Magnesium glycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 476818 | Magnesium glycinate | Designated preferred name (PT) | YES | |
| RxCUI: 476818 | Magnesium glycinate | Full form of descriptor (FN) | YES | |
| RxCUI: 476818 | Magnesium glycinate | Designated preferred name (PT) | YES | |
| RxCUI: 476818 | Magnesium glycinate | Full form of descriptor (FN) | YES | |
| RxCUI: 476825 | brompheniramine tannate 12 MG / phenylephrine tannate 20 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476825 | brompheniramine tannate 12 MG / phenylephrine tannate 20 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476825 | brompheniramine tannate 12 MG / phenylephrine tannate 20 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476826 | brompheniramine / phenylephrine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 476827 | sennosides 8.6 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476827 | sennosides 8.6 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476828 | niacinamide 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476828 | niacinamide 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476828 | niacinamide 4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476830 | niacinamide Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 476845 | glucosamine sulfate 750 MG / chondroitin sulfate A sodium 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476845 | glucosamine sulfate 750 MG / chondroitin sulfate A sodium 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476846 | chondroitin sulfate A sodium 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476847 | chondroitin sulfate A sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 476858 | magnesium hydroxide 1200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 476858 | magnesium hydroxide 1200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476858 | magnesium hydroxide 1200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 476859 | magnesium hydroxide 1200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 47686 | Urea hydrogen peroxide-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 47686 | Urea hydrogen peroxide-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 47686 | Urea hydrogen peroxide-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 47686 | Urea hydrogen peroxide-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 47686 | Urea hydrogen peroxide-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 47686 | Urea hydrogen peroxide-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 47686 | Urea hydrogen peroxide-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 47686 | Urea hydrogen peroxide-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476872 | nizatidine 75 MG in 5 mL Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 476872 | nizatidine 75 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476872 | nizatidine 75 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476872 | nizatidine 75 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 476872 | nizatidine 75 MG in 5 mL Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 476873 | nizatidine 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476874 | nizatidine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 47695 | Carbex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 476969 | guaifenesin 550 MG / phenylephrine hydrochloride 8.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476969 | guaifenesin 550 MG / phenylephrine hydrochloride 8.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 476970 | phenylephrine hydrochloride 8.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 476973 | menthol 5.8 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 476973 | menthol 5.8 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 476974 | ibuprofen 20 MG/ML Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 476975 | ibuprofen Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |